13/11/2018

Disclosure of Regulated Information as per Law 3556/2007

Diagnostic & Therapeutic Center of Athens HYGEIA SA (Issuer), acting in compliance with the legislation in force, announces that based on information received on November 13, 2018, from CVC Capital Partners SICAV-FIS SA (CVC SICAV) – acting on its behalf and on behalf of the companies controlled by it, i.e. CVC Capital Partners 2013 PCC, CVC MMXII Limited, CVC Portfolio Holdings Limited, CVC Group Holdings LP, CVC Capital Partners Finance Limited, CVC Capital Partners VI Limited, Hippocrates Holdings Jersey Limited, Hellenic Healthcare S.à.r.l and Hellenic Healthcare Single-Member Holdings SA (Hellenic Healthcare SA or CVC Entities when acting jointly with the aforementioned companies) – on November 12, 2018, Hellenic Healthcare SA acquired 34,010,963 ordinary registered shares of the Issuer in total, which correspond to approximately 11.12% of the total share capital and voting rights of the Issuer.

As a result,the voting right percentage of the Issuer held directly by Hellenic Healthcare SA and indirectly by each one of the other CVC Entities rose from approximately 70.38% – it had acquired on November 9, 2018 ­– to approximately 81.51%, a rate that corresponds to 249,200,429 ordinary registered shares of the Issuer.

This announcement constitutes regulated information, disclosed in compliance with the provisions of Law 3556/2007 and decision no. 1/434/3.7.2007 issued by the Board of Directors of the Hellenic Capital Market Commission, and has been posted in the Issuer's website (www.hygeia.gr).